A04206 | Pages: 206 | Apr 2021 | 27261 Views | ||
Author(s) : Kishor Sherkar, Apoorva Srivastava , Onkar Sumant | Tables: 117 | Charts: 23 |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Fertility Services Market
Request Now !The global fertility services market size generated $20,388.61 million in 2019 and is projected to reach $25,709.64 million by 2027, growing at a CAGR of 15.9% from 2020 to 2027.
COVID-19 outbreak had considerable impact across the world. The fertility services market has been negatively impacted by this pandemic. In addition, most fertility clinics across the globe have stopped undertaking new cases of infertility treatment for the next few months, till the condition seems to be under control.
Fertility services are services provided to support the treatment to cure infertility. These services involve techniques such as in vitro fertilization (IVF), artificial insemination, surrogacy, and others, which help in resolving infertility issues among couples, single mothers, and the LGBT community. Infertility can occur in men or women of child-bearing age. In addition, male infertility is identified majorly as a result of low sperm count or decreased motility of sperms, which may be due to hormonal imbalance. Hence, fertility in men and women requires proper functioning of hypothalamus and pituitary gland. Increase in the rate of infertility has occurred majorly due to factors such as increase in the consumption of alcohol and drugs, increased stress level, frequent smoking, obesity, and environmental factors. As per a study by the American Society for Reproductive medicines, in approximately 40% of infertile couples, the male partner is responsible for infertility and among them, approximately 85%–90% are treated with drugs or surgery. This is anticipated to drive the fertility services market growth.
Technological advancements in assisted reproductive technologies, rise in awareness regarding infertility treatment, and growth in number of fertility clinics are expected to drive the fertility services market growth during the forecast period. However, high cost related to the procedure along with stringent regulations pertaining to surrogacy in several countries restrict the growth of the market. Various factors that lead to infertility include problem with sperm or egg production, age, genetic factors, and excessive exposure to some chemicals and toxins. Alcohol consumption, steroid use, surgical removal of one of the testicles due to cancer, and diabetes can also result in low sperm count, thereby leading to infertility problems in men. In women, hormonal disorders, benign growths in uterus, abnormal anatomy of the cervix or uterus, blocked fallopian tubes, stress, chemotherapy, kidney, or sickle cell disease may result in infertility. Furthermore, rise in number of fertility clinics along with growth in awareness about fertility treatments such as sperm/egg donation and in-vitro fertilization escalates the adoption of fertility treatments, thereby propelling the market growth. Moreover, rise in infertility rates is not only due to lifestyle changes but also due to various diseases such as sexually transmitted diseases (STDs) and fertility-related diseases. Hence, the increase in infertility rates in the near future is anticipated to augment the growth of the fertility services market.
The fertility services market is classified into procedure, service, end user, and region. By procedure, the market is divided into IVF with intracytoplasmic sperm injection (ICSI), surrogacy, IVF without ICSI, intrauterine insemination (IUI), surrogacy, and others. By service, it is categorized into fresh non-donor, frozen non-donor, egg & embryo banking, fresh donor, and frozen donor. By end user, the market is segmented into fertility clinics, hospitals, surgical centers, and clinical research institutes. On the basis of region, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, the UK, France, Spain, Italy, Russia and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea and rest of Asia-Pacific), and LAMEA (Latin America, Middle East, and Africa).
By fertility services market analysis, the IVF with ICSI segment accounted for half of the market share in fertility services market in 2019. This segment is expected to exhibit a prominent growth rate, owing to some key factors such as higher success rates associated with ICSI-IVF in case of poor sperm morphology, poor sperm motility, low sperm count, and others. Moreover, rapid increase in infertility rate is one of the major factors that drives the growth of the fertility services market.
By procedure, the IVF with ICSI segment accounted for the largest market share in 2019. This segment is expected to exhibit a prominent growth rate, attributed to the fact that it has revolutionized male infertility treatment, as it requires smaller number of sperms that are penetrated into the egg with the help of injection technique.
Asia-Pacific presents lucrative opportunities for key players operating in the fertility services market, owing to increase in accessibility and availability of healthcare facilities and rise in healthcare and research expenditure. This region is anticipated to experience rapid market growth due to economic development. Moreover, the fertility services in countries such as India are cheaper as compared to the developed countries such as the U.S., Canada, and others; thereby, fueling the market growth in this region. The growth of the fertility services market is supplemented by surge in adoption of fertility procedures and rise in fertility tourism.
The key players operating in the global fertility services market include Apollo Hospitals Enterprise Ltd., Care Fertility Group, Carolinas Fertility Institute, Genea Limited, The Johns Hopkins Health System Corp, Medicover Group, Monash IVF Group, OvaScience Inc., Progyny Inc., and Xytex Cryo International. Other players in the value chain (not included in the report) include Irvine Scientific, INVO Bioscience, LifeGlobal Group, and IVFtech ApS.
Key Benefits For Stakeholders
Key Market Segments & Key Market Players
Segments | Sub-segments |
---|---|
By Procedure |
|
By Service |
|
By End User |
|
By Region |
|
Key Market Players | APOLLO HOSPITALS ENTERPRISE LTD., CARE FERTILITY GROUP LTD., CAROLINAS FERTILITY INSTITUTE, CITY FERTILITY, FERTILITY ASSOCIATES LIMITED, GENEA LIMITED, MEDICOVER GROUP (MEDICOVER FERTILITY and FIRST EGG BANK), MONASH IVF GROUP LIMITED, PROGYNY INC., VIRTUS HEALTH |
Loading Table Of Content...
This section provides the opinions of the top-level CXOs in the fertility services industry. According to the CXOs, fertility services refer to different assisted reproductive technology procedures undertaken by couples who cannot conceive naturally.
These services are availed to treat infertility. Different fertility procedures include in vitro fertilization (IVF), intrauterine insemination (IUI), surrogacy, and others. IVF is one of the most widely known fertility services offered by fertility clinics; this treatment is preferred for women with missing or blocked fallopian tubes. In addition, structural causes that cause infertility such as fibroids, endometriosis, cervical problems, and polycystic ovary syndrome also require IVF intervention.
According to the CXOs, the fertility services market is anticipated to witness considerable growth in future, owing to rise in prevalence of infertility, emerging trend of delayed pregnancies among women, technological advancements in assisted reproductive technology (ART) procedures, surge in male infertility, and increased incidence of gamete donations.
Moreover, increase in awareness about IVF and surge in popularity of medical & fertility tourism coupled with advanced ART facilities & treatment options are anticipated to supplement the market growth. However, inadequate reimbursement policies associated with fertility procedures are expected to impede the market growth during the forecast period.
The CXOs further state that growth in interest of single parents as well as same-sex couples in experiencing parenthood through ART and affordable fertility treatment offered in emerging markets such as India are expected to present lucrative opportunities for the market expansion.
This section provides the opinions of the top-level CXOs in the fertility services industry. According to the CXOs, fertility services refer to different assisted reproductive technology procedures undertaken by couples who cannot conceive naturally.
These services are availed to treat infertility. Different fertility procedures include in vitro fertilization (IVF), intrauterine insemination (IUI), surrogacy, and others. IVF is one of the most widely known fertility services offered by fertility clinics; this treatment is preferred for women with missing or blocked fallopian tubes. In addition, structural causes that cause infertility such as fibroids, endometriosis, cervical problems, and polycystic ovary syndrome also require IVF intervention.
According to the CXOs, the fertility services market is anticipated to witness considerable growth in future, owing to rise in prevalence of infertility, emerging trend of delayed pregnancies among women, technological advancements in assisted reproductive technology (ART) procedures, surge in male infertility, and increased incidence of gamete donations.
Moreover, increase in awareness about IVF and surge in popularity of medical & fertility tourism coupled with advanced ART facilities & treatment options are anticipated to supplement the market growth. However, inadequate reimbursement policies associated with fertility procedures are expected to impede the market growth during the forecast period.
The CXOs further state that growth in interest of single parents as well as same-sex couples in experiencing parenthood through ART and affordable fertility treatment offered in emerging markets such as India are expected to present lucrative opportunities for the market expansion
A. Infertility is a disease of the reproductive system defined by the failure to achieve a clinical pregnancy after 12 months or more of regular unprotected sexual intercourse
A. Top companies such as Apollo Hospitals Enterprise Ltd., Care Fertility Group, Carolinas Fertility Institute, Genea Limited and others held a high market position in 2019. These key players held a high market postion owing to the strong geographical foothold in different regions.
A. IVF with intracytoplasmic sperm injection (ICSI), surrogacy, IVF without ICSI, intrauterine insemination (IUI), surrogacy, and others.
A. The market value of fertility services market in 2027 is $25,709.64 million.
A. The total market value of fertility services market was $20,388.61 million in 2019.
A. The forcast period for fertility services market is 2020 to 2027
A. In procedure segment IVF with ICSI is the most influencing segment. This segment is expected to exhibit a prominent growth rate, owing to some key factors such as higher success rates associated with ICSI-IVF in case of poor sperm morphology, poor sperm motility, low sperm count, and others. In addition, rise in awareness regarding IVF with ICSI also have a positive effect on the market.
A. The base year is 2019 for the fertility services market
A. The major factor that fuels the growth of the global fertility services market includes continuous decline in fertility rates, trend of delayed pregnancy in women, and technological advancements with respect to fertility treatment is expected growth of the market. On the contrary, developing economies and untapped markets are expected to provide lucrative opportunities for the market growth in the future.
A. Asia-Pacific has the highest growth rate in the market which is growing due to the contribution of the emerging countries. This is due to the fertility services in countries such as India are cheaper as compare to the developed countries such as the U.S., Canada, and others; thereby, fueling the market growth of fertility services in this region, development in healthcare infrastructure, and rise in number of hospitals & research centers equipped with advanced medical facilities.
Start reading instantly.
This Report and over 13,000+ more Reports, Available with Avenue Library. T&C*.
10%
Discount
10%
Discount
15%
Discount
15%
Discount
Enterprise
License/PDF
20%
Discount
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers